Hall & Wilcox advises private equity owned PharmaLex GmbH on Australian acquisition


Hall & Wilcox has advised leading international medical technology consultancy PharmaLex GmbH on its acquisition of a majority interest in Australian health science consultancy Brandwood CKC. PharmaLex is a portfolio company of elite German based private equity firm Auctus Capital Partners AG.

Hall & Wilcox advised on the due diligence, assisted with drafting and negotiating all transaction documents, and provided regulatory advice. The merger aligns with PharmaLex’s objective to strengthen its presence in Australia, New Zealand and the broader global markets of the Asia-Pacific region.

Corporate & Commercial Partner Oliver Jankowsky led the Hall & Wilcox team, supported by Senior Associate Chevi Levin and Lawyer David Holland. Corporate Partner Alison Choy Flannigan, who also leads the firm’s Health & Community industry group, provided guidance on regulatory matters, and Senior Associate Jeanette Lui assisted with the banking and financial services aspects of the transaction.

Commenting on the deal, Partner Oliver Jankowsky said: ‘We provided pragmatic advice to our client, who was represented by experienced M&A professionals from Auctus Capital Partners AG. This cross-border deal had some particular complexities, but we managed to complete the matter in the target timeframe.’

Auctus in-house counsel Dr Ulrich Müller said, ‘We very much appreciated the hands-on approach of Oliver and his team. They provided great advice related to the complex shareholder structure and also for the specific medical-related issues that came up during the deal.’

PharmaLex provides specialised services for the pharmaceutical, biotech and medical device industries to enable companies to maximise their development process and reduce their time to market. Brandwood CKC provides regulatory, technical, and commercial services for developers, manufacturers and suppliers of medical devices, diagnostics and pharmaceutical products. Brandwood CKC will continue to operate its current name before transitioning to PharmaLex later in the year.

Hall & Wilcox is a leading independent Australian law firm of around 750 people including over 90 partners, delivering legal services to corporate, public sector and private clients, both Australian-based and those offshore doing business in Australia. The Hall & Wilcox Mergers & Acquisitions team is widely recognised, including being listed in The Legal 500. The firm’s Health & Community group advises the health, lifesciences (pharmaceuticals, medical devices and health and medical research), aged care, retirement living, disability, education and community service sectors.


Melinda Woledge

Melinda Woledge

Marketing & Communications Manager

Melinda is the Marketing & Communications Manager. She is responsible for the external and internal communication strategy.

You might be also interested in...

Corporate & Commercial | 13 May 2021

Hall & Wilcox advises Big Ant Studios on its €35 million acquisition by French-based acquirer

Hall & Wilcox has advised sports video game maker Big Ant Studios on its €35 million acquisition by French-based company Nacon SA.

Insolvency & Restructuring | 19 Apr 2021

Hall & Wilcox launches market-first PPSA online issue-spotting tool for insolvency practitioners

Hall & Wilcox has launched the market-first online PPSA Checklist, an issue-spotting tool to help insolvency practitioners streamline their assessment of creditor claims.